In Brief: FDA's Ear, Nose and Throat Devices Panel
This article was originally published in The Gray Sheet
FDA's Ear, Nose and Throat Devices Panel: May 21 meeting agenda includes review of a PMA for a cochlear implant for use in children ages 2-17. The meeting begins at 8:00 a.m. in the Gaithersburg, Maryland Hilton. For further information, contact FDA's Marilyn Flack at 301/594-2080...
You may also be interested in...
Jazz and PharmaMar need to see what further data will be needed to convert their FDA authorization into a full approval following disappointing results in the ATLANTIS Phase III trial.
As arguments rage over whether the UK regulator has rushed its assessment of the Pfizer/BioNTech vaccine, the European Medicines Agency explains why its conditional marketing authorization approach is taking a little longer.
The IVDR implementation schedule is problematic. European notified bodies say solutions must be grasped if public health is not to suffer.